Erdostin Capsule (Erdosteine)

Adult dose

Adults: Administer 300 mg of erdosteine orally per dose, 2～3 times daily. Do not administer continuously for more than 10 days when treating acute respiratory diseases.

This medication should not be used in certain patients. First, individuals who have an allergic reaction to this medication or its components should not take it. Patients with cirrhosis or those with cystathionine synthase deficiency should avoid it, as its metabolites can affect methionine metabolism. Patients with peptic ulcers should also refrain from using this medicine. Patients with severely impaired kidney function or severely damaged liver function should not take this medication. Additionally, this medication contains lactose, so patients with hereditary conditions such as galactose intolerance, lactose deficiency, or glucose-galactose malabsorption should not take it. There are also patients who need to be cautious when taking this medication. Patients with mild to moderate liver impairment should use it with caution, not exceeding 300 mg per day. Diabetic patients or those on a calorie-restricted diet should be particularly careful when using syrup formulations. This medication contains a dye called Yellow No. 5; individuals with allergies or hypersensitivity to this component should take it cautiously. In case of overdose, symptoms may include sweating, dizziness, and facial flushing. Gastrointestinal symptoms such as headache, cold symptoms, difficulty breathing, taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn may also occur while taking this medication. Allergic reactions on the skin, such as hives, erythema, or eczema, may also develop. Post-marketing surveillance reports in South Korea have noted adverse reactions including fatigue, dyspepsia, palpitations, facial or systemic swelling, itching, weakness, drowsiness, and rash. Be cautious when using this medication with expectorants, as it may increase the risk of bronchitis infection due to the difficulty in expelling bronchial mucus caused by cough relief, and bronchospasm may occur. Women who are pregnant or breastfeeding should refrain from taking this medication, as its safety has not been adequately established. This medication should be kept out of reach of children and should not be transferred to another container, as this may pose a risk of accidents and decrease the quality.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the efficacy of the medication.

Appearance

Hard capsule with a green upper part and an amber yellow lower part, filled with white powder

Package unit

30 capsules/bottle, 100 capsules/bottle, 300 capsules/bottle, 500 capsules/bottle